Costly drug to manufacture at volume so any generics manufacturers would have to run a very close ruler over the economics of taking that on in terms of their own return. Either way, it's a long way down the track.
- Forums
- ASX - By Stock
- Let’s compare valuations based off Acadias price for Daybue
Costly drug to manufacture at volume so any generics...
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$14.73 |
Change
0.180(1.24%) |
Mkt cap ! $1.882B |
Open | High | Low | Value | Volume |
$14.71 | $14.80 | $14.58 | $7.694M | 523.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10244 | $14.73 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.75 | 894 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10244 | 14.730 |
1 | 1372 | 14.570 |
1 | 350 | 14.550 |
1 | 500 | 14.540 |
2 | 78 | 14.510 |
Price($) | Vol. | No. |
---|---|---|
14.750 | 894 | 2 |
14.800 | 911 | 3 |
14.850 | 450 | 2 |
14.880 | 840 | 2 |
14.950 | 2000 | 1 |
Last trade - 16.10pm 24/01/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
AVM
ADVANCE METALS LIMITED
Adam McKinnon, MD
Adam McKinnon
MD
SPONSORED BY The Market Online